Most Popular
-
1
Korea’s homegrown nanosatellite successfully launches into space
-
2
[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
-
3
Nicaragua shuts down Seoul embassy
-
4
Ador CEO denies allegations, accuses Hybe of mistreating NewJeans
-
5
Hybe's multilabel system tested amid conflict with Ador
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
-
6
Rocket engine expert, ex-NASA exec to lead Korea's new space agency
-
7
SNU profs to suspend treatment for one day
-
8
SK hynix pledges W20tr to ramp up DRAM production at home
-
9
Over-50s, men, single-person households take up majority of those filing for bankruptcy
-
10
Pianist Cho Seong-Jin named Berlin Philharmonic's artist-in-residence
The Korean drug safety authority said Monday that it is directly reviewing products containing metformin, the Type 2 diabetes treatment whose commercialized variants in Singapore have been tested to contain an unacceptable level of a cancer-causing impurity.
This impurity, called N-nitrosodimethylamine, or NDMA, was found in three out of 46 metformin finished products sold in Singapore. Singapore’s Health Sciences Authority recalled the products.
This impurity, called N-nitrosodimethylamine, or NDMA, was found in three out of 46 metformin finished products sold in Singapore. Singapore’s Health Sciences Authority recalled the products.
Metformin is widely used to treat Type 2 diabetes patients, and as a first-in-class drug it has no known substitute.
Korea’s Ministry of Food and Drug Safety said none of the three recalled products had been sold in Korea. The MFDS said that it is carrying out tests of over 640 metformin drugs in Korea as precautionary measure.
Patients are not advised to halt the medication on their own without doctor’s consultation, the MFDS cautioned.
By Lim Jeong-yeo (kaylalim@heraldcorp.com)
![[KH Explains] Korean shipbuilding stocks rally: Real growth or bubble?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/25/20240425050656_0.jpg&u=)
